傳藝科技(002866.SZ):10名董事及高管擬合計減持不超25.8萬股
格隆匯2月7日丨傳藝科技(002866.SZ)公佈,公司於2020年2月7收到公司董事會祕書、董事、副總經理許小麗,董事、副總經理單國華,董事、副總經理劉賽平,董事張所朝,副總經理李靜,副總經理劉林,副總經理陳桂林,副總經理陳桂鬆,副總經理張清,財務總監劉文華十人的《股份減持計劃告知函》,上述十位股東計劃在減持計劃公告之日起15個交易日後的6個月內減持公司股份,通過集中競價方式合計減持公司股份不超過25.8萬股,佔截至目前公司總股本約2.49億股的0.1037%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.